SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-015760
Filing Date
2022-08-09
Accepted
2022-08-09 07:34:11
Documents
58
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cogt-20220630.htm   iXBRL 10-Q 1905760
2 EX-10.1 cogt-ex10_1.htm EX-10.1 165903
3 EX-31.1 cogt-ex31_1.htm EX-31.1 16592
4 EX-31.2 cogt-ex31_2.htm EX-31.2 16580
5 EX-32.1 cogt-ex32_1.htm EX-32.1 11119
6 EX-32.2 cogt-ex32_2.htm EX-32.2 11094
7 GRAPHIC img156520917_0.jpg GRAPHIC 60030
  Complete submission text file 0000950170-22-015760.txt   6754864

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cogt-20220630.xsd EX-101.SCH 45472
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cogt-20220630_def.xml EX-101.DEF 170596
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cogt-20220630_pre.xml EX-101.PRE 269702
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cogt-20220630_lab.xml EX-101.LAB 361034
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cogt-20220630_cal.xml EX-101.CAL 39530
52 EXTRACTED XBRL INSTANCE DOCUMENT cogt-20220630_htm.xml XML 991668
Mailing Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140
Business Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140 617-945-5576
Cogent Biosciences, Inc. (Filer) CIK: 0001622229 (see all company filings)

IRS No.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38443 | Film No.: 221146420
SIC: 2834 Pharmaceutical Preparations